12 results
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
#Diabetes #T2D ... #DM2 #Table #PrimaryCare
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
and metformin in T2D ... peptide- I receptor agonist ... sulfonylurea; T2D ... type 2 diabetes; TZD ... type 2 diabetes; TZD
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... patients with T2D ... GLP1 #Receptor #Agonists ... Pharmacology #Summary #DM2
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
#diabetes #T2DM ... GLP-1 receptor agonist ... sulfonylurea; TZD
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
SENSITIZER • TZD ... - PPAR gamma agonist ... AGENTS • GLP-1 agonists ... #pharmacology #DM2
Type 2 Diabetes handout for patients. 
#diabetes #t2d #dm2 #low carb diet #HA1C #patient education #endocrinology
#diabetes #t2d # ... dm2 #low carb diet
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
patients with T2D ... mL/minute/1.73 m2 ... Pharmacology #Summary #DM2
The “twin cycles” of diabetes, first introduced by Roy Taylor in 2008.  
#fatty liver #fatty
pancreas #diabetes #t2d ... #dm2 #insulin resistance
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD ... GLP-1 receptor agonist ... Diabetes #Mellitus #DM2
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
patients with T2D ... ml/min per 1.73 m2